Pharmaceuticals
Samsung Biologics bumps Hyundai from Korean market's top 3
Drugmaker's market cap surges to $31bn on lucrative virus treatment deal
Drugmaker's market cap surges to $31bn on lucrative virus treatment deal
THine touts software for public venues, screening people with masks
South Korean chipmaker sees profit fall 40% on year but rebounds from previous quarter
Voice recognition specialist first to reveal cost of sanctions for alleged abuses
Export package reveals edge large companies have over startups during crisis
Allure of lifetime 'membership' fades in race for Japan's top graduates
Chinese tech giant faces sharply slowing sales amid coronavirus
Suppliers asked to crank out 5G parts despite coronavirus fears
Son of founder pursued internal change at Kyoto-based electronic parts company
M&A maestro changes his tune, preferring cash on hand
South Korean engineers allowed to skip quarantine despite infection risk
Suppliers told to prepare for 10% increase in production
Industry leader Vinatex weighs furloughs for 50,000 as coronavirus saps demand
Your weekly lineup of Asia's biggest business and political news
South Korean companies lose market share as free-spending Chinese peers close in
Travel bans leave tech suppliers unable to bring in production advisers
28,000-plus companies have entered the sector amid booming demand
Biotech unit to field clients directly as safety concerns mount
Tie-up to start with OLED panels with ultrasonic fingerprint sensors
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.